| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0016-5085(91)90215-7 |
| P698 | PubMed publication ID | 1985041 |
| P2093 | author name string | F Creed | |
| B Tomenson | |||
| D Dawson | |||
| E Guthrie | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | irritable bowel syndrome | Q838966 |
| P304 | page(s) | 450-7 | |
| P577 | publication date | 1991-02-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | A controlled trial of psychological treatment for the irritable bowel syndrome | |
| P478 | volume | 100 |
| Q88622366 | A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study |
| Q40525285 | A collaborative health care model for the treatment of irritable bowel syndrome |
| Q33425327 | A one year follow-up of relaxation response meditation as a treatment for irritable bowel syndrome |
| Q52007027 | A sense of proportion: the place of psychiatry in medicine. |
| Q71359335 | Anxiety, depression and management of medically unexplained symptoms in medical clinics |
| Q34170707 | Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors? |
| Q36023411 | Biofeedback treatment of gastrointestinal disorders |
| Q35579339 | British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome |
| Q56005412 | CHRONIC FATIGUE SYNDROME |
| Q24671910 | CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome |
| Q91792226 | Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS) |
| Q55312184 | Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. |
| Q51947500 | Cognitive behavior therapy for functional gastrointestinal disorders: is group treatment effective? |
| Q34212933 | Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders |
| Q37282285 | Complementary and alternative medicine for IBS in adults: mind-body interventions |
| Q81478235 | Consensus guidelines for the management of chronic pelvic pain |
| Q36682652 | Constipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factors |
| Q33283471 | Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). |
| Q74256158 | Diarrhea- and Constipation-predominant Irritable Bowel Syndrome |
| Q35336680 | Drug treatment of the irritable bowel syndrome |
| Q34000626 | Effects of fasting therapy on irritable bowel syndrome |
| Q47686007 | Emotional awareness and expression training improves irritable bowel syndrome: A randomized controlled trial. |
| Q35513973 | Evidence-based clinical practice guidelines for irritable bowel syndrome. |
| Q37062585 | Five personality dimensions in patients with irritable bowel syndrome |
| Q36901988 | Fortnightly Review: Irritable bowel, irritable body, or irritable brain? |
| Q74588436 | Frequent attenders without organic disease in a gastroenterology clinic. Patient characteristics and health care use |
| Q36072268 | Functional abdominal bloating with distention |
| Q72188638 | Functional bowel disorders. A multicenter comparison of health status and development of illness severity index |
| Q33734181 | Functional somatic syndromes: one or many? |
| Q35486799 | Functional symptoms in neurology: questions and answers |
| Q41697392 | Gastrointestinal diseases in women |
| Q35557629 | Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease |
| Q53431095 | Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life. |
| Q34626602 | Guidelines on the irritable bowel syndrome: mechanisms and practical management. |
| Q40861862 | Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility |
| Q36654463 | Involvement of parasympathetic pelvic efferent pathway in psychological stress-induced defecation |
| Q73236914 | Irritable Bowel Syndrome |
| Q36888811 | Irritable bowel or irritable mind? Psychological treatment is essential for some |
| Q73374014 | Irritable bowel syndrome |
| Q74306259 | Irritable bowel syndrome |
| Q93941183 | Irritable bowel syndrome |
| Q36653122 | Irritable bowel syndrome. Strategy for the family physician |
| Q35351736 | Level of chronic life stress predicts clinical outcome in irritable bowel syndrome |
| Q55342420 | Liaison Psychiatry for the 21st Century: A Review |
| Q43070882 | New drugs in the management of the irritable bowel syndrome |
| Q35178785 | New insights into the psychosocial aspects of irritable bowel syndrome |
| Q34040358 | New therapies for functional bowel diseases |
| Q37231312 | Norepinephrine mediates the transcriptional effects of heterotypic chronic stress on colonic motor function |
| Q34375132 | Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders |
| Q35176952 | Overview of functional gastrointestinal disorders: dysfunction of the brain-gut axis |
| Q33788432 | Patient subgroups in irritable bowel syndrome that can be defined by symptom evaluation and physical examination |
| Q34382950 | Personality factors and profiles in variants of irritable bowel syndrome. |
| Q35045698 | Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome. |
| Q33658394 | Psychiatric Comorbidities and Environmental Triggers in Patients with Chronic Daily Headache: A Lifestyle Study |
| Q38572987 | Psychodynamic therapy meets evidence-based medicine: a systematic review using updated criteria |
| Q38068401 | Psychogenic nonepileptic seizures: a treatment review. What have we learned since the beginning of the millennium? |
| Q74256178 | Psychologic Therapies for Irritable Bowel Syndrome |
| Q34549642 | Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases |
| Q24234269 | Psychological interventions for non-ulcer dyspepsia |
| Q24244278 | Psychological interventions for non-ulcer dyspepsia |
| Q24246619 | Psychological interventions for non-ulcer dyspepsia |
| Q67732651 | Psychological treatment for the irritable bowel syndrome |
| Q24241516 | Psychological treatments for the management of irritable bowel syndrome |
| Q51117034 | Psychometric scores and persistence of irritable bowel after infectious diarrhoea. |
| Q95270765 | Psychotherapeutic Interventions in Irritable Bowel Syndrome |
| Q34309891 | Quality of life in irritable bowel syndrome |
| Q36320350 | Randomised controlled trial of brief psychological intervention after deliberate self poisoning |
| Q95812130 | Randomised controlled trials in psychiatry. Trials show that psychotherapy is effective for wide range of psychological conditions |
| Q36803795 | Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment |
| Q92234614 | Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome |
| Q40441543 | Review article: functional dyspepsia—should treatment be targeted on disturbed physiology? |
| Q44957012 | Self-management for women with irritable bowel syndrome |
| Q26771442 | Short-term and Long-term Efficacy of Psychological Therapies for Irritable Bowel Syndrome: A Systematic Review and Meta-analysis |
| Q24194930 | Short-term psychodynamic psychotherapies for common mental disorders |
| Q24244099 | Short-term psychodynamic psychotherapies for common mental disorders |
| Q43151566 | Should purchasers pay for psychotherapy? |
| Q24539149 | Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care? |
| Q39228203 | The contribution of epidemiology to psychosomatic medicine. |
| Q33423372 | The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study |
| Q33788458 | The relationship between psychosocial parameters and outcome in irritable bowel syndrome |
| Q34081797 | The role of psychosocial factors in gastrointestinal disorders. |
| Q51104678 | The short-term natural history of irritable bowel syndrome: a time-series analysis. |
| Q33788426 | Therapeutic approach to the patient with irritable bowel syndrome |
| Q83513936 | [Alternative treatments in irritable bowel syndrome] |
| Q79242482 | [Functional gastrointestinal disorders] |
Search more.